1. Medtech Insight
  2. >>Device Area
  3. >>Diabetic Care

Don’t Develop It. Buy It! Tandem Buys AMF To Save Years Of R&D

 
• By Barnaby Pickering

To accelerate the development of its own patch-based insulin pump, Tandem Diabetes has purchased AMF Medical.

Handshake
• Source: Shutterstock

Tandem Diabetes Care, manufacturer of the T:slim X2 insulin pump, has purchasedAMF Medical, the Swiss developer of the Sigi Patch Pump, in a deal that could be worth up to $215m.

Expected to close in January 2023 – a rapid turnaround for an M&A deal of this size – the purchase comprises of a CHF 62

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diabetic Care

More from Device Area

First At-Home Cervical Cancer Screening Tool Gets FDA Clearance

 
• By Elizabeth Orr

The US FDA has approved the Teal Wand, the first at-home cervical cancer screening device. Capable of detecting preclinical cancer with 96% accuracy, it will launch in California in June and expand nationwide soon after.

SS Innovations Files For De Novo For SSi Mantra 3 Surgical Robotic System For Multispecialty Indications

 
• By Marion Webb

SS Innovations announced plans to file a de novo application with the US FDA for its SSi Mantra 3 surgical robot, already approved for marketing in six countries. The Florida-based firm also plans to pursue the CE mark for European commercialization.

The Value Of Consumer Wearables Within The Clinic Is Currently Unknown, Says Cardiologist

 
• By Natasha Barrow

“It’s quite likely [consumer wearable manufacturers] are changing the sensitivity and specificity based on consumer feedback, but not for medical reasons,” said Dipak Kotecha, a University of Birmingham professor of cardiology. Often, self-reported performance evidence from manufacturers is “low quality and biased.”